HIV replication inhibiting purine derivatives

Details for Australian Patent Application No. 2004274185 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Koymans, Lucien Maria Henricus; Heeres, Jan; Vandenput, Dirk Alfons Leo; Vinkers, Hendrik Maarten; Janssen, Paul Adriaan Jan; De Jonge, Marc Rene; Lewi, Paulus Joannes; Daeyaert, Frederik Frans Desire; Leenders, Ruben Gerardus George

Agent Shelston IP

Pub. Number AU-B-2004274185

PCT Pub. Number WO2005/028479

Priority PCT/EP03/50659 25.09.03 EP

Filing date 21 September 2004

Wipo publication date 31 March 2005

Acceptance publication date 10 December 2009

International Classifications

A61K 31/52 (2006.01)

C07D 473/00 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

C07D 473/18 (2006.01) Heterocyclic compounds containing purine ring systems

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/028479 Priority application(s): WO2005/028479

10 December 2009 Application Accepted

  Published as AU-B-2004274185

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274187-Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

2004274184-Thiazole derivatives as cannabinoid receptor modulators